Smith & Nephew (LON:SN) Receives “Sector perform” Rating from Royal Bank Of Canada

Smith & Nephew (LON:SN)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank Of Canada in a research report issued to clients and investors on Monday,Digital Look reports. They currently have a GBX 1,350 target price on the stock. Royal Bank Of Canada’s target price would suggest a potential upside of 18.58% from the company’s previous close.

A number of other equities analysts have also weighed in on the stock. UBS Group reaffirmed a “neutral” rating and issued a GBX 1,300 target price on shares of Smith & Nephew in a research note on Tuesday, May 5th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a GBX 1,400 price target on shares of Smith & Nephew in a report on Thursday, June 11th. Berenberg Bank reaffirmed a “hold” rating and set a GBX 13 price objective on shares of Smith & Nephew in a research report on Friday, May 1st. Finally, Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,760 price objective on shares of Smith & Nephew in a report on Thursday, May 21st. Three equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of GBX 1,382.62.

Smith & Nephew Stock Performance

Shares of LON SN opened at GBX 1,138.50 on Monday. The company has a debt-to-equity ratio of 62.90, a quick ratio of 0.84 and a current ratio of 2.57. The firm has a market capitalization of £12.48 billion, a PE ratio of 40.99, a P/E/G ratio of 0.46 and a beta of 0.67. The firm’s 50-day moving average price is GBX 1,143.91 and its 200 day moving average price is GBX 1,211.61.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.